The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults - The Lancet Healthy Longevity
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology
Lancet Diabetes and Endocrinology,The
The Lancet Diabetes & Endocrinology, May 2020, Volume 8, Issue 5, Pages 349-456
Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study - The Lancet Regional Health – Europe
Lancet Diabetes and Endocrinology,the impact factor and... | Exaly
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey - The Lancet Diabetes & Endocrinology
Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study - The Lancet Diabetes & Endocrinology
The Lancet, 24 June 2023, Volume 401, Issue 10394, Pages 2087-2162
Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records - The Lancet Diabetes & Endocrinology
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people - The Lancet Diabetes & Endocrinology
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives - The Lancet
Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact - The Lancet
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 - The Lancet Diabetes & Endocrinology
Type 1 diabetes—early life origins and changing epidemiology - The Lancet Diabetes & Endocrinology
Type 2 diabetes - The Lancet
The impact of race and socioeconomic factors on paediatric diabetes - eClinicalMedicine
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis - The Lancet
Frontiers | COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment - The Lancet Diabetes & Endocrinology
Judging journals' impact - The Lancet Diabetes & Endocrinology
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study - The Lancet Diabetes & Endocrinology
The Lancet Diabetes & Endocrinology | Journal | ScienceDirect.com by Elsevier
Potential health and economic impact associated with achieving risk factor control in Chinese adults with diabetes: a microsimulation modelling study - The Lancet Regional Health – Western Pacific
Environmental risk factors for type 1 diabetes
Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study - The Lancet Diabetes & Endocrinology
